Moreover an elegant study published after the current work was completed showed that AML cells with an undifferentiated phenotype have prolonged in vivo survival when mTOR activity is knocked out, and that subsequent mTOR re-activation restores the leukaemogenic potential of these cells [42]. This evidence concerns the gene MTOR and acute myeloid leukemia.